TLR3 and neoplasm: The reported tumor-suppressive, anti-angiogenic, and apoptotic effects of TLR3 activation in the tumor microenvironment have predominantly been attributed to the induction of type I IFN and activation of effector cells that impair proliferation and induce apoptosis in tumor cells.